The estimated Net Worth of Michael V. Chobotov is at least $215 Thousand dollars as of 5 August 2016. Michael Chobotov owns over 14,000 units of Endologix stock worth over $41,639 and over the last 9 years Michael sold ELGX stock worth over $173,600.
Michael has made over 1 trades of the Endologix stock since 2016, according to the Form 4 filled with the SEC. Most recently Michael sold 14,000 units of ELGX stock worth $173,600 on 5 August 2016.
The largest trade Michael's ever made was selling 14,000 units of Endologix stock on 5 August 2016 worth over $173,600. On average, Michael trades about 4,667 units every 0 days since 2016. As of 5 August 2016 Michael still owns at least 189,269 units of Endologix stock.
You can see the complete history of Michael Chobotov stock trades at the bottom of the page.
Michael's mailing address filed with the SEC is 3805 SKYFARM DRIVE, , SANTA ROSA, CA, 95403.
Over the last 22 years, insiders at Endologix have traded over $72,068,611 worth of Endologix stock and bought 306,824 units worth $2,023,811 . The most active insiders traders include International, L.P. Elliott, Associates, L.P. Elliott, and Capital Management Lp Camber. On average, Endologix executives and independent directors trade stock every 27 days with the average trade being worth of $13,088. The most recent stock trade was executed by Dan Lemaitre on 4 September 2020, trading 51,844 units of ELGX stock currently worth $2,592.
Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.
Endologix executives and other stock owners filed with the SEC include: